An Ayurvedic pragmatic approach to Non-alcoholic Steatohepatitis vis-à-vis Yakritodara by Dr. Shirvadkar Divyashree M et al.
  
 
                                                   REVIEW ARTICLE July-Aug 2019 
 
Journal of Ayurveda and Integrated Medical Sciences | July - Aug  2019 | Vol. 4 | Issue 4 328 
 
An Ayurvedic pragmatic approach to Non-alcoholic 
Steatohepatitis vis-à-vis Yakritodara 
Dr. Shirvadkar Divyashree M1, Dr. Prashanth A. S.,2 Dr. S. G. Chavan3  
1Post Graduate Scholar, 2Professor & Head, 3Professor, Department of Kayachikitsa, Ayurveda Mahavidyalaya, 


















The liver is the most massive organ of the viscera 
occupying a substantial portion of the abdominal 
cavity. It is wedge shaped weighing about 1.2-1.5kg 
and is divided into largest right and much smaller left 
lobe. It is the only organ of the viscera that can 
regenerate.The liver is the key organ which regulates 
the homeostasis in the body responsible for the 
production and excretion of bile, metabolism of 
proteins, carbohydrates, lipids, storage of vitamins 
and  detoxification  of  the  toxic  substances  such   as  
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alcohol, drugs etc. Due to the advanced technology 
and the busy schedule, the lifestyle of an individual 
has become sedentary along with lack of exercise and 
there is increased popularity of fast foods leading to 
the impairment of metabolism in an individual making 
him prone to a series of disorders called as ‘lifestyle 
disorders’ which has a direct impact on the liver and 
its functions. 
Non Alcoholic Steatohepatitis (NASH) represents a 
part of a wide spectrum of Non Alcoholic Fatty Liver 
Disease (NAFLD) which ranges from simple Steatosis 
and Steatohepatitis to advanced Fibrosis and 
Cirrhosis.[1]The occurrence of Non Alcoholic 
Steatohepatitis in Type 2 Diabetics, Obese and 
Hypertriglyceridemics is exceedingly high. Also, the 
risk of severe liver disease goes up with the increasing 
features of ‘Metabolic Syndrome’.[2] Global prevelance 
of NAFLD is estimated at 24% with highest rates in the 
Middle East and South America and lowest inAfrica.[3] 
Epidemiological studies suggest the prevalence of 
NAFLD is around 9% to 32% of general population in 
India with a higher prevalence in those with Obesity 
and Diabetes.[4] 
A B S T R A C T  
Liver is considered to be the key organ of the body as it is concerned with filtration, metabolism, 
detoxification and other vital functions. Non Alcoholic Steatohepatitis (NASH) represents a part of a 
wide spectrum of Non Alcoholic Fatty Liver Disease (NAFLD). NASH is typically associated with 
Obesity, Type II Diabetes, Dyslipidemia and the Metabolic Syndrome. Epidemiological studies suggest 
the prevalence of NAFLD is around 9% to 32% of general population in India with a higher prevalence 
in those with Obesity and Diabetes. It can be understood that the Nidana and Samprapti of 
Yakritodara is similar to the etiopathogenesis of Non-alcoholic Steatohepatitis (NASH). Ayurveda 
known for its safe and cost effective medication has a great potential in treating NASH. Virechana 
being the most suitable Shodhana Karma is indicated in liver disorders in Bahu Doshavastha and 
Srotorodha. Hence, it is the need of the hour to search an effective and safe Hepatoprotective ideal 
remedy from the Ayurvedic treasure of therapeutics for the welfare of mankind. 
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Liver is compared with Yakrit mentioned in Ayurvedic 
classics. Acharya Bhavamishra was the first to 
introduce the term ‘Yakrit Vikara’ with its 
classification in his treatise Bhavaprakasha.[5] There is 
no direct reference available in the Ayurvedic classics 
correlating to Non Alcoholic Steatohepatitis (NASH). 
Non Alcoholic Fatty Liver disease (NAFLD) is a 
Santarpanajanya Vyadhi and based on the Nidana, 
Samprapti and Lakshanas, we can correlate it with 
Kaphaja Yakritodara.[6] 
Non Alcoholic Steatohepatitis (NASH) is a large, 
untapped market with no FDA (Food and Drug 
Administrative agency) approved therapeutics. In 
spite of the tremendous advances made in modern 
medicine, still there is a need of effective and safe 
Hepatoprotective medicines. Hence, it is the need of 
the hour to search an effective and safe 
Hepatoprotective ideal remedy from Ayurvedic 
treasure of therapeutics for the welfare of mankind.  
Embryological origin and physiological perspective of 
Yakrit  
During Garbhavastha, Yakrit is formed from Rakta 
Dhatu itself during the 3rd to 7th month.[7] Acharya 
Bhavamishra explained, Yakrit is situated on the right 
side below the Hridaya, it is formed from Shonita and 
is the seat of Ranjaka Pitta.[8] Yakrit is derived from 
the Matruja bhava[9] and is the Mulasthana of 
Raktavaha srotas.[10] Samana Vayu brings the Aahara 
Rasa into the Hridaya where it is converted into the 
Rasa Dhatu which when reaches the Yakrit and Pleeha 
gets converted into Rakta Dhatu due to the Ushnata 
of Ranjaka pitta.[11] 
Etio-Pathogenesis : Modern and Ayurvedic 
Perspective 
Heavy fat rich diet, junk foods, soft drinks sedentary 
lifestyle, Metabolic syndrome (Obesity, Diabetes 
Mellitus, Dyslipidemia, Hypertension), drugs like (eg: 
Corticosteroids, Aspirin, Tetracycline) etc. are 
considered tobe the major etiological factors of Non 
Alcoholic Steatohepatitis.[12] 
According to Bhavaprakasha, Vidahi, Abhishyandi 
Ahara like Madhya, Kulatha, Masha, Mahisha Dadhi 
causes Rakta and Kapha Dushti[13] leading to the 
Dushti of Rasavaha, Raktavaha, Medovaha, Annavaha 
and Pureeshavaha Srotas and thereby producing 
“Kaphaja Yakritodara”. Ajirna (Indigestion), Sthoulya 
(Obesity) and Prameha (Diabetes Mellitus) which also 
occur due to the Dushti of Annavaha, Rasavaha and 
Medovaha Srotas acts as Nidanarthakara Rogas 
(Diseases which cause another diseases) which may 
result in the manifestation of Non Alcoholic 
Steatohepatitis. 
Several mechanisms have been postulated to explain 
the pathogenesis of Non Alcoholic Steatohepatitis. 
The currently favoured is ‘Two Hit Hypothesis’ which 
explains why not everyone with fatty liver disease 
develops hepatic fibrosis. The ‘first hit’ results in 
steatosis (fatty liver) which is only complicated by 
inflammation. If a ‘second hit’ occurs, Leptin, which is 
an appetite reducer and a fibrogenicin vitro, is 
probably then needed to cause hepatic fibrosis. The 
components of first hit includes the release of free 
fatty acids from central adipose tissue, along with 
adipokines, drain into the portal vein as well as 
causing insulin resistance. These processes result in 
reduced hepatic fatty acid oxidation and increased 
fatty acid synthesis. 
Fatty liver occurs as a result of increased fat import 
into hepatocytes and reduced fat export. Insulin 
resistance causes hepatic steatosis, which also 
perpetuates insulin resistance. Subsequent activation 
of TNF-alpha, oxidant stress through the production of 
reactive oxygen species and production of endotoxins 
thenresult in inflammation and eventually fibrosis. 
Factors including leptin are probably needed for 
fibrosis.[14] 
Similarly,according to Ayurvedic perspective, the 
Vidahi-Abhishyandi Aahara and Vihara leads to 
Agnivikruti and formation of Apakva Anna Rasa 
resulting in Kapha Dushti (Bahu Drava Sleshma) and 
impaired fatty acid metabolism. The improper 
formation and deposition of Abaddha Medas occurs in 
Yakrit leading to Medovriddhi. This process results in 
Steatosis (fat deposition in liver). The Kapha and 
Medo Dushti causes Srotorodha that leads to Vata 
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Prakopa and causing Agnidipti. When Pitta gets 
involved in the Samprapti, hepatocytes have 
inflammatory changes and the disease progresses to 
the next level i.e. Non Alcoholic Steatohepatitis 
(Steatosis + Inflammation). The Prakupita Vata further 
causes Dhatu Paaka leading to Fibrosis and the 
condition may progress to its drastic end stages 
Cirrhosis, Ascites, Hepato cellular Carcinoma and also 
paveway to other metabolic complications.  
Lakshanas 
Agninasha (Loss of appetite), Avipaka (Indigestion), 
Arochaka (Anorexia), Udarashoola (Dull aching 
abdominal pain in the right hypochondriac region), 
Anaaha (Abdominal bloating), Chardi (Vomiting), 
Pandu (Anemia), Mrudu Jwara (Fever), Dourbalya 
(Fatigue).[15] 
Samprapti Ghataka 
▪ Dosha  -  Tridosha - Samanavayu, Apanavayu, 
Pachakapitta, Ranjakapitta, Kledaka Kapha 
▪ Dushya - Rasa, Rakta, Meda 
▪ Agni    - Jataragni, Dhatvagni 
▪ Ama - Jataragni and Dhatwagnimandhyajanya 
Ama 
▪ Srotas - Rasavaha, Raktavaha, Medovaha, 
Annavaha, Pureeshavaha 
▪ Sanchara - Siras 
▪ Srotodushti Prakara - Sanga 
▪ Udbhava Sthana - Amashaya 
▪ Vyakta Sthana - Udara 
▪ Adhishtana - Yakrit 
▪ Vyadhi Swabhava - Chirakari 
▪ Rogamarga - Abhyantara 
▪ Sadhyasadhyata - Krichrasadhya 
Chikitsa 
There is no established treatment for Non Alcoholic 
Steatohepatitis (NASH) in conventional medical 
science. Initial approach involves dietary 
modifications based on Metabolic Profile (Obesity, 
Diabetes, Hyperlipidemia, Hypertension) and getting 
patients to increased levels of physical activity. The 
stage of liver damage from healthy liver to Steatosis 
and Steatohepatitis is reversible. But, as the damage 
progresses further to Fibrosis and Cirrhosis, the 
condition becomes irreversible. Hence, steps should 
be taken to treat the disease at the initial stages and 
to stop it from progressing to the irreversible 
condition. 
According to Bhavaprakasha, the Hetu, Samprapti and 
Lakshanas mentioned for Pleehodara are similar to 
that of Yakritodara. The only difference is that the 
Sthana of Pleeha is Vaama Parshva and that of Yakrit 
is Dakshina Parshva.[16] 
The root cause of all the Udara Rogas is Prakupita 
Vata Dosha and Mala Sanchaya. Hence, 
Vatanulomana should be carried out repeatedly in all 
the Udara Rogas.[17] Virechana is the most suitable 
Shodhana Karma in liver disorders. It is the best 
remedy for Pittaja and Raktaja Roga[18] and is 
indicated in BahuDoshavastha and Srotorodha. 
“Natisnigdha Shariraay Dadhyat Sneha Virechanam| 
Sneha Utkilshta Shariraay Ruksham Dadhyat 
Virechanam||”[19] 
As Non Alcoholic Steatohepatitis is a Santarpanajanya 
Vyadhi, Ruksha Virechana should be given. If Snigdha 
Virechana is given in Atisnigdha individuals, then due 
to the Atisnigdhata, the Doshas will get adhered in 
the other Srotas. Hence, Ruksha Virechana is 
indicated. The management should be the breakdown 
of pathological factors like Agnivaigunya, Srotorodha 
and Kaphamedodushti. Agnideepana, Rookshana, 
Srotoshodhana, Kapha, Meda and Vata Dushti 
Chikitsa. When Fatty Liver progresses to next stage 
and Dhatus get involved, treatment should be 
directed towards Prasadana of Rasa and Rakta and 
also Yakritshothahara Chikitsa. 
Importance of Guda Ardraka Yoga in Yakritodara 
Charaka has explained the importance of Guda 
Aadraka Prayoga. Intake of Guda (Jaggery) and 
Aadraka starts with ½ Pala (24 ml) Pramana on the 
first day and there after, by increasing ½ Pala Matra 
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per day upto a maximum of 5 Pala Matra (10th day). 
This Matra should be kept constant and continued for 
a period of another 20 days. It acts as Kapha 
Shamaka, Deepana, Pachana, Shulahara. This Yoga 
can also be indicated in Avipaka, Kamala, Gulma, 
Arsha, Shotha, Prameha, Shwasa, Kasa and 
Pratishyaya.[20] 
Importance of Gomutra Haritaki Prayoga in 
Yakritodara[21] 
Gomutra and Haritaki both possess Kapha and 
Medoghna properties due to the dominance of Agni 
and Vayu Mahabhuta. Haritaki has Gunas like 
Kashaya, Ruksha, Ushna, Anulomana and Gomutra 
possesses Gunas like Katu, Tikshna, Ushna, Kshara. 
Gomutra is Kapha Shodhaka and Haritaki is 
Vatanulomaka. Hence, Gomutra Haritaki acts as 
Deepana, Kaphahara, Vatanulomaka, Srotoshodhaka, 
Shophahara and there by, helps in the breakdown of 
the pathological factors (Agnivaigunya, Srotorodha 
and Kaphamedodushti) responsible for Non Alcoholic 
Steatohepatitis. 
Important Yogas 
The drugs which possess the properties like Rechana, 
Vatashamaka, Agnivardhaka; Aama, Meda and Kapha 
Nashaka are preferable in Non Alcoholic 
Steatohepatitis. Various formulations of Churna, Vati, 
Kashaya, Asava-Arishta Kalpanas and Rasoushadhi’s 
arementioned in classical texts which can widely be 
used for this purpose.  
▪ Churna Yogas - Narayana Churna, Pippali Churna, 
Neelinada Churna, Hapushadya Churna, Patoladi 
Churna, Mahasudarshana Churna. 
▪ Vati Kalpanas - Chitrakadi Vati, Rohitakadi Vati, 
Agnitundi Vati, Arogyavardhini Vati. 
▪ Kashaya Kalpanas - Vasaguduchyadi Kashaya, 
Patola katurohinyadi Kashaya, Patolamooladi 
Kashaya, Varanadi Kashaya, Phalatrikadi Kwatha. 
▪ Asava-Arishta Kalpanas - Rohitakarishta, 
Pippalyasava, Kumaryasava, Kalameghasava. 
▪ Rasoushadhis - Yakrit-Plihari Loha, Icchabhedi 
Rasa, Pleehantaka Rasa, Lokanath Rasa, Plihari 
Rasa. 
All the above Yogas are well known for their 
hepatoprotective properties and can be effectively 
used in the management of Non Alcoholic 
Steatohepatitis. 
CONCLUSION 
Non Alcoholic Steatohepatitis (NASH) is the 
inflammation of liver and damage caused by the build 
up of fat in the liver. It can be understood that the 
etiopathogenesis of Non Alcoholic Steatohepatitis is 
similar to the Nidana and Samprapti of Yakritodara 
which is developed due to the vitiation of Kapha and 
Pitta. Virechana is the most suitable Shodhana Karma 
in liver disorders, being the best remedy for Pittaja 
and Raktaja Roga’s. The stage of liver damage from 
healthy liver to Steatosis and Steatohepatitis is 
reversible. But, as the damage progresses further to 
Fibrosis and Cirrhosis, the condition becomes 
irreversible. So, steps should be taken to treat the 
disease at the initial stages and to stop it from 
progressing to the irreversible condition. Hence, it is 
the need of the hour to search an effective and safe 
Hepatoprotective ideal remedy from Ayurvedic 
treasure of therapeutics for the welfare of mankind. 
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